CA2853677C - Methods and materials for enzymatic synthesis of mogroside compounds - Google Patents
Methods and materials for enzymatic synthesis of mogroside compounds Download PDFInfo
- Publication number
- CA2853677C CA2853677C CA2853677A CA2853677A CA2853677C CA 2853677 C CA2853677 C CA 2853677C CA 2853677 A CA2853677 A CA 2853677A CA 2853677 A CA2853677 A CA 2853677A CA 2853677 C CA2853677 C CA 2853677C
- Authority
- CA
- Canada
- Prior art keywords
- polypeptide
- mogroside
- amino acid
- seq
- sequence identity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229930189775 mogroside Natural products 0.000 title claims abstract description 59
- 238000000034 method Methods 0.000 title claims abstract description 38
- 150000001875 compounds Chemical class 0.000 title claims abstract description 32
- 238000003786 synthesis reaction Methods 0.000 title claims abstract description 9
- 230000015572 biosynthetic process Effects 0.000 title abstract description 8
- 239000000463 material Substances 0.000 title abstract description 8
- 230000002255 enzymatic effect Effects 0.000 title abstract description 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 86
- 229920001184 polypeptide Polymers 0.000 claims description 83
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 83
- JLYBBRAAICDTIS-AYEHCKLZSA-N mogrol Chemical compound C([C@H]1[C@]2(C)CC[C@@H]([C@]2(C[C@@H](O)[C@]11C)C)[C@@H](CC[C@@H](O)C(C)(C)O)C)C=C2[C@H]1CC[C@H](O)C2(C)C JLYBBRAAICDTIS-AYEHCKLZSA-N 0.000 claims description 34
- JLYBBRAAICDTIS-UHFFFAOYSA-N mogrol Natural products CC12C(O)CC3(C)C(C(CCC(O)C(C)(C)O)C)CCC3(C)C1CC=C1C2CCC(O)C1(C)C JLYBBRAAICDTIS-UHFFFAOYSA-N 0.000 claims description 33
- 150000001413 amino acids Chemical group 0.000 claims description 32
- 238000006243 chemical reaction Methods 0.000 claims description 20
- 230000013595 glycosylation Effects 0.000 claims description 16
- 238000006206 glycosylation reaction Methods 0.000 claims description 16
- 108020004414 DNA Proteins 0.000 claims description 13
- 239000013604 expression vector Substances 0.000 claims description 10
- 230000001279 glycosylating effect Effects 0.000 claims description 10
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims description 9
- 241000700605 Viruses Species 0.000 claims description 8
- 239000013592 cell lysate Substances 0.000 claims description 8
- 230000000694 effects Effects 0.000 claims description 7
- 230000001419 dependent effect Effects 0.000 claims description 6
- 101100483372 Arabidopsis thaliana UGT73C5 gene Proteins 0.000 claims description 5
- 102000000340 Glucosyltransferases Human genes 0.000 claims description 5
- 108010055629 Glucosyltransferases Proteins 0.000 claims description 5
- 210000004027 cell Anatomy 0.000 claims description 5
- 239000013612 plasmid Substances 0.000 claims description 5
- 101100483369 Arabidopsis thaliana UGT73C3 gene Proteins 0.000 claims description 4
- 101100483373 Arabidopsis thaliana UGT73C6 gene Proteins 0.000 claims description 4
- 102000005720 Glutathione transferase Human genes 0.000 claims description 4
- 108010070675 Glutathione transferase Proteins 0.000 claims description 4
- 108010043121 Green Fluorescent Proteins Proteins 0.000 claims description 4
- 102000004144 Green Fluorescent Proteins Human genes 0.000 claims description 4
- 101100483376 Stevia rebaudiana UGT73E1 gene Proteins 0.000 claims description 4
- 101100048059 Stevia rebaudiana UGT85C2 gene Proteins 0.000 claims description 4
- 239000005090 green fluorescent protein Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 3
- 230000028327 secretion Effects 0.000 claims description 3
- 241000238631 Hexapoda Species 0.000 claims description 2
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 108010031100 chloroplast transit peptides Proteins 0.000 claims description 2
- 210000004962 mammalian cell Anatomy 0.000 claims description 2
- 244000005700 microbiome Species 0.000 claims description 2
- 230000002438 mitochondrial effect Effects 0.000 claims description 2
- 210000002706 plastid Anatomy 0.000 claims description 2
- 238000003259 recombinant expression Methods 0.000 claims description 2
- 241001515965 unidentified phage Species 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 3
- 239000008103 glucose Substances 0.000 claims 3
- 150000007523 nucleic acids Chemical class 0.000 description 25
- 108020004707 nucleic acids Proteins 0.000 description 21
- 102000039446 nucleic acids Human genes 0.000 description 21
- GHBNZZJYBXQAHG-KUVSNLSMSA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8s,9r,10r,11r,13r,14s,17r)-17-[(2r,5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-3-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GHBNZZJYBXQAHG-KUVSNLSMSA-N 0.000 description 13
- TVJXHJAWHUMLLG-UHFFFAOYSA-N mogroside V Natural products CC(CCC(OC1OC(COC2OC(CO)C(O)C(O)C2OC3OC(CO)C(O)C(O)C3O)C(O)C(O)C1O)C(C)(C)O)C4CCC5(C)C6CC=C7C(CCC(OC8OC(COC9OC(CO)C(O)C(O)C9O)C(O)C(O)C8O)C7(C)C)C6(C)C(O)CC45C TVJXHJAWHUMLLG-UHFFFAOYSA-N 0.000 description 13
- 235000013399 edible fruits Nutrition 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 239000000543 intermediate Substances 0.000 description 5
- 102000053602 DNA Human genes 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- WRPAFPPCKSYACJ-ZBYJYCAASA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8r,9r,10s,11r,13r,14s,17r)-17-[(5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-hydroxy-6-methylheptan-2-yl]-11-hydrox Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H](CCC(C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@@H]3[C@]2(C)CC1)C)C(C)(C)O)[C@H]1O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]1O WRPAFPPCKSYACJ-ZBYJYCAASA-N 0.000 description 3
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 3
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- WSPRAEIJBDUDRX-UHFFFAOYSA-N Euferol Natural products CC12CCC3(C)C(C(CCC=C(C)C)C)CCC3(C)C1CC=C1C2CCC(O)C1(C)C WSPRAEIJBDUDRX-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 108010059820 Polygalacturonase Proteins 0.000 description 3
- 241001409321 Siraitia grosvenorii Species 0.000 description 3
- WSPRAEIJBDUDRX-FBJXRMALSA-N cucurbitadienol Chemical compound C([C@H]1[C@]2(C)CC[C@@H]([C@]2(CC[C@]11C)C)[C@@H](CCC=C(C)C)C)C=C2[C@H]1CC[C@H](O)C2(C)C WSPRAEIJBDUDRX-FBJXRMALSA-N 0.000 description 3
- 108010093305 exopolygalacturonase Proteins 0.000 description 3
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 229930191869 mogroside IV Natural products 0.000 description 3
- OKGRRPCHOJYNKX-UHFFFAOYSA-N mogroside IV A Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)C(CO)O5)O)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O OKGRRPCHOJYNKX-UHFFFAOYSA-N 0.000 description 3
- WRPAFPPCKSYACJ-UHFFFAOYSA-N mogroside IV E Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)C(CO)O5)O)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O WRPAFPPCKSYACJ-UHFFFAOYSA-N 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 150000003648 triterpenes Chemical group 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- XJIPREFALCDWRQ-UYQGGQRHSA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6s)-3,4-dihydroxy-6-[(3r,6r)-2-hydroxy-6-[(3s,8s,9r,10r,11r,13r,14s,17r)-11-hydroxy-4,4,9,13,14-pentamethyl-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1h-cyclop Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XJIPREFALCDWRQ-UYQGGQRHSA-N 0.000 description 2
- 241000228245 Aspergillus niger Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- -1 mogroside la Chemical class 0.000 description 2
- 238000002953 preparative HPLC Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- XJIPREFALCDWRQ-UHFFFAOYSA-N siamenoside I Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(CO)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC(C(C(O)C1O)OC2C(C(O)C(O)C(CO)O2)O)OC1COC1OC(CO)C(O)C(O)C1O XJIPREFALCDWRQ-UHFFFAOYSA-N 0.000 description 2
- 239000007974 sodium acetate buffer Substances 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
- CGGWHBLPUUKEJC-HRTKKJOOSA-N (3S,8R,9R,10R,13R,14S,17R)-17-[(2R,5R)-5-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-6-hydroxy-6-methylheptan-2-yl]-4,4,9,13,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-11-one Chemical compound C[C@H](CC[C@@H](O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(C)(C)O)[C@H]1CC[C@@]2(C)[C@H]3CC=C4[C@@H](CC[C@H](O[C@@H]5O[C@H](CO[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@@H](O)[C@H](O)[C@H]5O)C4(C)C)[C@]3(C)C(=O)C[C@]12C CGGWHBLPUUKEJC-HRTKKJOOSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- CGGWHBLPUUKEJC-UHFFFAOYSA-N 11-oxomogroside V Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)C(CO)O5)O)O4)O)CC4)(C)C)C4C3(C)C(=O)CC2(C)C1C(C)CCC(C(C)(C)O)OC(C(C(O)C1O)OC2C(C(O)C(O)C(CO)O2)O)OC1COC1OC(CO)C(O)C(O)C1O CGGWHBLPUUKEJC-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 1
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 230000007023 DNA restriction-modification system Effects 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 102000051366 Glycosyltransferases Human genes 0.000 description 1
- 108700023372 Glycosyltransferases Proteins 0.000 description 1
- 241000713666 Lentivirus Species 0.000 description 1
- 102000003792 Metallothionein Human genes 0.000 description 1
- 108090000157 Metallothionein Proteins 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 235000006092 Stevia rebaudiana Nutrition 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 241000723873 Tobacco mosaic virus Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- HSCJRCZFDFQWRP-JZMIEXBBSA-N UDP-alpha-D-glucose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-JZMIEXBBSA-N 0.000 description 1
- HSCJRCZFDFQWRP-UHFFFAOYSA-N Uridindiphosphoglukose Natural products OC1C(O)C(O)C(CO)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-UHFFFAOYSA-N 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 229940068517 fruit extracts Drugs 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 238000012868 site-directed mutagenesis technique Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
- C12P33/20—Preparation of steroids containing heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161563303P | 2011-11-23 | 2011-11-23 | |
| US61/563,303 | 2011-11-23 | ||
| PCT/IB2012/002857 WO2013076577A1 (en) | 2011-11-23 | 2012-11-19 | Methods and materials for enzymatic synthesis of mogroside compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2853677A1 CA2853677A1 (en) | 2013-05-30 |
| CA2853677C true CA2853677C (en) | 2019-01-29 |
Family
ID=47624376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2853677A Active CA2853677C (en) | 2011-11-23 | 2012-11-19 | Methods and materials for enzymatic synthesis of mogroside compounds |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US9920349B2 (enExample) |
| EP (1) | EP2783009B1 (enExample) |
| JP (1) | JP6084983B2 (enExample) |
| KR (1) | KR101791597B1 (enExample) |
| CN (1) | CN103958693B (enExample) |
| AU (2) | AU2012342114B2 (enExample) |
| BR (1) | BR112014012543A2 (enExample) |
| CA (1) | CA2853677C (enExample) |
| IN (1) | IN2014CN03557A (enExample) |
| MX (1) | MX342851B (enExample) |
| MY (1) | MY170686A (enExample) |
| RU (1) | RU2633644C2 (enExample) |
| SG (1) | SG11201401927PA (enExample) |
| WO (1) | WO2013076577A1 (enExample) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY185668A (en) | 2010-06-02 | 2021-05-28 | Evolva Inc | Recombinant production of steviol glycosides |
| KR102114493B1 (ko) | 2011-08-08 | 2020-05-26 | 에볼바 에스아 | 스테비올 글리코시드의 재조합 생산 |
| IN2014CN03557A (enExample) | 2011-11-23 | 2015-10-09 | Evolva Sa | |
| TW201402599A (zh) * | 2012-05-30 | 2014-01-16 | Suntory Holdings Ltd | 甜菊糖苷糖苷轉化酵素及編碼該酵素之基因 |
| HK1215053A1 (zh) | 2012-12-04 | 2016-08-12 | Evolva Sa | 用作生物合成罗汉果化合物的方法及材料 |
| WO2016050890A2 (en) * | 2014-10-01 | 2016-04-07 | Evolva Sa | Methods and materials for biosynthesis of mogroside compounds |
| CN105189771B (zh) | 2013-02-11 | 2019-11-05 | 埃沃尔瓦公司 | 在重组宿主中有效产生甜菊醇糖苷 |
| EP3179869A1 (en) | 2014-08-11 | 2017-06-21 | Evolva SA | Production of steviol glycosides in recombinant hosts |
| JP2017528134A (ja) | 2014-09-09 | 2017-09-28 | エヴォルヴァ エスアー．Ｅｖｏｌｖａ Ｓａ． | 組み換え宿主におけるステビオールグリコシドの生産 |
| WO2016038617A1 (en) | 2014-09-11 | 2016-03-17 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) | Methods of producing mogrosides and compositions comprising same and uses thereof |
| WO2016060276A1 (ja) | 2014-10-17 | 2016-04-21 | サントリーホールディングス株式会社 | モグロール配糖体化酵素およびそれをコードする遺伝子 |
| JP6850130B2 (ja) | 2015-01-20 | 2021-03-31 | サントリーホールディングス株式会社 | モグロシドの調製方法 |
| EP3250686A1 (en) | 2015-01-30 | 2017-12-06 | Evolva SA | Production of steviol glycosides in recombinant hosts |
| CN115851470B (zh) | 2015-03-16 | 2025-09-02 | 帝斯曼知识产权资产管理有限公司 | Udp-糖基转移酶 |
| AU2016307066A1 (en) | 2015-08-07 | 2018-02-08 | Evolva Sa | Production of steviol glycosides in recombinant hosts |
| NZ741741A (en) | 2015-10-29 | 2019-08-30 | Senomyx Inc | High intensity sweeteners |
| CN106924274B (zh) * | 2015-12-29 | 2019-01-04 | 成都普睿法药物研发有限公司 | 葫芦烷型四环三萜类化合物抗肺纤维化应用 |
| MY198001A (en) | 2016-04-13 | 2023-07-25 | Evolva SA | Production of steviol glycoside in recombinant hosts |
| US10815514B2 (en) | 2016-05-16 | 2020-10-27 | Evolva Sa | Production of steviol glycosides in recombinant hosts |
| EP3458598A1 (en) * | 2016-05-16 | 2019-03-27 | Evolva SA | Production of steviol glycosides in recombinant hosts |
| WO2018016483A1 (ja) * | 2016-07-19 | 2018-01-25 | サントリーホールディングス株式会社 | モグロールまたはモグロール配糖体の生産方法 |
| US11396669B2 (en) | 2016-11-07 | 2022-07-26 | Evolva Sa | Production of steviol glycosides in recombinant hosts |
| BR112019023104A2 (pt) | 2017-05-03 | 2020-11-03 | Firmenich Incorporated | métodos para fazer adoçante de alta intensidade |
| EP3624595A4 (en) | 2017-05-19 | 2021-03-03 | The Coca-Cola Company | COMPOSITIONS SWEETED WITH SIAMENOSIDE I AND USES THEREOF |
| EP3629764A1 (en) | 2017-06-02 | 2020-04-08 | Givaudan SA | Compositions |
| WO2021214008A1 (en) | 2020-04-20 | 2021-10-28 | Givaudan Sa | Compositions |
| US11248248B2 (en) | 2017-06-15 | 2022-02-15 | Evolva Sa | Production of mogroside compounds in recombinant hosts |
| CN107189976B (zh) * | 2017-07-28 | 2022-03-11 | 李华政 | 促进罗汉果ugt72b21基因表达的方法 |
| CN113286523A (zh) | 2018-11-07 | 2021-08-20 | 弗门尼舍公司 | 制备高强度甜味剂的方法 |
| WO2020096905A1 (en) | 2018-11-07 | 2020-05-14 | Firmenich Incorporated | Methods for making high intensity sweeteners |
| US12234464B2 (en) | 2018-11-09 | 2025-02-25 | Ginkgo Bioworks, Inc. | Biosynthesis of mogrosides |
| CN110669094B (zh) * | 2019-10-14 | 2021-12-21 | 上海交通大学 | 罗汉果新苷及其制备方法 |
| KR102362135B1 (ko) * | 2019-10-25 | 2022-02-14 | 고려대학교 산학협력단 | 테르펜 당쇄 부가 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 조성물 |
| BR112022018627A2 (pt) * | 2020-03-17 | 2022-12-20 | Coca Cola Co | Sistemas e métodos inovadores de produção de mogrosídeo |
| GB202007984D0 (en) | 2020-05-28 | 2020-07-15 | Givaudan Sa | Compositions |
| CN112063647B (zh) * | 2020-09-17 | 2023-05-02 | 云南农业大学 | 酿酒酵母重组菌Cuol01的构建方法、酿酒酵母重组菌Cuol02及应用 |
| CN116064712B (zh) * | 2022-10-08 | 2025-05-06 | 中国药科大学 | 一种罗汉果醇的生物合成方法 |
| EP4698673A1 (en) | 2023-04-20 | 2026-02-25 | DSM IP Assets B.V. | Strains and methods for the production of mogrosides |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6399321B1 (en) * | 1999-08-18 | 2002-06-04 | National Research Council Of Canada | Methods for screening UDP-glucose:glycoprotein glucosyltransferase (UGGT) activity and nucleic acid encoding for UGGT |
| EP1510573A1 (en) * | 2003-09-01 | 2005-03-02 | Austria Wirtschaftsservice Gesellschaft mit beschränkter Haftung | Method for detoxification of mycotoxins |
| US20080148432A1 (en) * | 2005-12-21 | 2008-06-19 | Mark Scott Abad | Transgenic plants with enhanced agronomic traits |
| CA2598792A1 (en) | 2005-03-02 | 2006-09-08 | Metanomics Gmbh | Process for the production of fine chemicals |
| US8257948B1 (en) * | 2011-02-17 | 2012-09-04 | Purecircle Usa | Method of preparing alpha-glucosyl Stevia composition |
| US8956677B2 (en) | 2005-11-23 | 2015-02-17 | The Coca-Cola Company | High-potency sweetener composition with glucosamine and compositions sweetened therewith |
| RU2455853C2 (ru) * | 2005-11-23 | 2012-07-20 | Дзе Кока-Кола Компани | Композиция интенсивного подсластителя с пищевой клетчаткой и подслащенные ею композиции |
| US7927851B2 (en) | 2006-03-21 | 2011-04-19 | Vineland Research And Innovation Centre | Compositions having ent-kaurenoic acid 13-hydroxylase activity and methods for producing same |
| WO2008062165A2 (en) * | 2006-11-22 | 2008-05-29 | The University Of York | Monoterpenoid modifying enzymes |
| WO2008065370A2 (en) | 2006-12-01 | 2008-06-05 | The University Of York | Sesquiterpenoid modifying enzymes |
| GB0904639D0 (en) * | 2009-03-18 | 2009-04-29 | Univ York | Assay |
| MY185668A (en) | 2010-06-02 | 2021-05-28 | Evolva Inc | Recombinant production of steviol glycosides |
| IN2014CN03557A (enExample) | 2011-11-23 | 2015-10-09 | Evolva Sa | |
| HK1215053A1 (zh) | 2012-12-04 | 2016-08-12 | Evolva Sa | 用作生物合成罗汉果化合物的方法及材料 |
-
2012
- 2012-11-19 IN IN3557CHN2014 patent/IN2014CN03557A/en unknown
- 2012-11-19 EP EP12819015.4A patent/EP2783009B1/en active Active
- 2012-11-19 SG SG11201401927PA patent/SG11201401927PA/en unknown
- 2012-11-19 US US14/356,782 patent/US9920349B2/en active Active
- 2012-11-19 KR KR1020147016910A patent/KR101791597B1/ko active Active
- 2012-11-19 RU RU2014125216A patent/RU2633644C2/ru not_active IP Right Cessation
- 2012-11-19 JP JP2014542951A patent/JP6084983B2/ja active Active
- 2012-11-19 WO PCT/IB2012/002857 patent/WO2013076577A1/en not_active Ceased
- 2012-11-19 AU AU2012342114A patent/AU2012342114B2/en active Active
- 2012-11-19 MY MYPI2014001482A patent/MY170686A/en unknown
- 2012-11-19 MX MX2014006276A patent/MX342851B/es active IP Right Grant
- 2012-11-19 BR BR112014012543A patent/BR112014012543A2/pt unknown
- 2012-11-19 CN CN201280057518.8A patent/CN103958693B/zh active Active
- 2012-11-19 CA CA2853677A patent/CA2853677C/en active Active
-
2017
- 2017-09-26 AU AU2017235907A patent/AU2017235907A1/en not_active Withdrawn
-
2018
- 2018-02-06 US US15/889,743 patent/US10738340B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN103958693B (zh) | 2016-08-24 |
| EP2783009B1 (en) | 2016-04-13 |
| US20180237819A1 (en) | 2018-08-23 |
| BR112014012543A2 (pt) | 2017-06-13 |
| IN2014CN03557A (enExample) | 2015-10-09 |
| US20140308698A1 (en) | 2014-10-16 |
| EP2783009A1 (en) | 2014-10-01 |
| AU2012342114A1 (en) | 2014-05-22 |
| AU2017235907A1 (en) | 2017-10-12 |
| CA2853677A1 (en) | 2013-05-30 |
| JP6084983B2 (ja) | 2017-02-22 |
| US10738340B2 (en) | 2020-08-11 |
| RU2633644C2 (ru) | 2017-10-16 |
| MX342851B (es) | 2016-10-14 |
| KR20140099281A (ko) | 2014-08-11 |
| AU2012342114B2 (en) | 2017-12-21 |
| JP2014533518A (ja) | 2014-12-15 |
| MY170686A (en) | 2019-08-26 |
| SG11201401927PA (en) | 2014-09-26 |
| MX2014006276A (es) | 2014-10-13 |
| RU2014125216A (ru) | 2015-12-27 |
| US9920349B2 (en) | 2018-03-20 |
| WO2013076577A1 (en) | 2013-05-30 |
| CN103958693A (zh) | 2014-07-30 |
| KR101791597B1 (ko) | 2017-10-30 |
| HK1200494A1 (zh) | 2015-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2853677C (en) | Methods and materials for enzymatic synthesis of mogroside compounds | |
| Shibuya et al. | Identification and characterization of glycosyltransferases involved in the biosynthesis of soyasaponin I in Glycine max | |
| AU2022204430A1 (en) | Methods and materials for biosynthesis of mogroside compounds | |
| US20250331481A1 (en) | Group of udp-glycosyltransferase for catalyzing carbohydrate chain elongation, and application thereof | |
| Kim et al. | Production of bioactive flavonol rhamnosides by expression of plant genes in Escherichia coli | |
| US20160215306A1 (en) | Method for producing modified resveratrol | |
| AU2018220068A1 (en) | Methods for improved production of rebaudioside D and rebaudioside M | |
| JP7305213B2 (ja) | 変異体酵素を介するステビオール配糖体レバウシオシドｉの生合成的産生 | |
| Lyu et al. | Identification and characterization of three flavonoid 3-O-glycosyltransferases from Epimedium koreanum Nakai | |
| CN104357418A (zh) | 一种糖基转移酶及其突变体在合成人参皂苷Rh2中的应用 | |
| CN106350565A (zh) | 一种稀有人参皂苷Rh2的生产方法 | |
| Zhang et al. | Identification of the key residues of the uridine diphosphate glycosyltransferase 91D2 and its effect on the accumulation of steviol glycosides in Stevia rebaudiana | |
| CN105087739A (zh) | 一种新的制备稀有人参皂苷的催化体系及其应用 | |
| WO2021147575A1 (zh) | 新型碳苷糖基转移酶及其应用 | |
| WO2021164673A1 (zh) | 双功能碳苷糖基转移酶及其应用 | |
| Overwin et al. | Flavanone and isoflavone glucosylation by non-Leloir glycosyltransferases | |
| Yang et al. | Systems metabolic engineering of Escherichia coli to enhance the production of flavonoid glucuronides | |
| WO2023030065A1 (zh) | 一种糖基转移酶及其应用 | |
| HK1200494B (en) | Methods and materials for enzymatic synthesis of mogroside compounds | |
| Xu et al. | Convergent Evolution and De Novo Reconstitution of Apiin Biosynthesis | |
| Nidetzky | Glycosyltransferase cascades made fit for the biocatalytic production of natural product glycosides | |
| Masada et al. | Full Text HTML |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20160825 |